期刊文献+

宫颈癌组织高危型HPV感染与HWAPL蛋白表达的关系 被引量:12

Relationship of high-risk HPV infection and HWAPL protein expression in cervical cancer tissue
下载PDF
导出
摘要 目的:检测宫颈癌组织中人乳头瘤病毒(HPV)感染率及人半翼基因(HWAPL)蛋白表达水平,探讨高危型HPV感染与HWAPL蛋白表达的关系。方法:收集宫颈上皮内瘤变(CIN)组织及宫颈癌组织石蜡标本共132例,其中CINⅠ29例、CINⅡ28例、CINⅢ35例、宫颈癌40例,应用HPV分型基因芯片系统检测其内HPV并分型,应用PV-9000法进行HWAPL染色。结果:宫颈癌和CINⅢ组织中高危型HPV阳性率高于CINⅡ和CINⅠ组织(χ2=34.560,P<0.001)。宫颈癌和CIN组织中HWAPL蛋白表达强度比较,差异有统计学意义(H=58.981,P<0.001)。高危型HPV感染与HWAPL蛋白表达有关联(rP=0.356,P=0.001)。结论:HWAPL蛋白异常表达可能是高危型HPV致宫颈癌发病的重要环节。 Aim:To detect the infection rate of high-risk HPV and the expression level of HWAPL in cervical cancer tissue and to investigate the relationship between them .Methods:Gene chip technology was used to detect HPV genoty-ping,at the same time PV-9000 immunohistochemistry was used to detect HWAPL protein expression in 132 specimens(in-cluding CINⅠ29 cases, CINⅡ28 cases, CINⅢ35 cases, and cervical cancer 40 cases).Results:The positive rates of high-risk HPV in cervical cancer and CINⅢwere significantly higher than those in CINⅡ and CINⅠ(χ2 =34.560,P〈0.001).The expression level of HWAPL protein in cervical cancer and CIN were significantly different (H=58.981,P〈0.001).High-risk HPV infection was positively correlated with HWAPL protein expression (rP =0.356,P =0.001). Conclusion:The abnormal expression of HWAPL may be an important part for high-risk HPV induced cervical cancer .
出处 《郑州大学学报(医学版)》 CAS 北大核心 2014年第6期862-865,共4页 Journal of Zhengzhou University(Medical Sciences)
关键词 宫颈癌 HPV HWAPL cervical cancer HPV HWAPL
  • 相关文献

参考文献7

二级参考文献17

  • 1杨毅,王友芳,郎景和,程雪梅,李彩娟,单莹,俞梅.高危型人乳头瘤病毒杂交捕获法Ⅱ评估宫颈上皮内瘤变的临床价值[J].中国医学科学院学报,2006,28(3):395-398. 被引量:43
  • 2黄谟婉,马英.宫颈癌研究新进展[J].重庆医学,2006,35(23):2185-2187. 被引量:7
  • 3曹春霞,马军,寻萌,薛欣,陈萍,楚雍烈.宫颈癌相关新癌基因hWAPL的原核表达和免疫原性分析[J].细胞与分子免疫学杂志,2007,23(6):562-564. 被引量:1
  • 4Pan Q, Belinson JL,Li L,et al. A thin-layer, liquid-based pap test for mass screening in an area of China with a high incidence of cervical carcinoma: a cross-sectional, compar-ative study[ J]. Acta Cytol, 2003, 47( 1 ) :45.
  • 5Munoz N, Bosch FX, de Sanjos6 S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer[J]. N EnglJMed, 2003, 348(6) :518.
  • 6Gandhi R, Gillespie PJ, Hirano T. Human wapl is a cohesion-bind- ing protein that promotes sister2chromatid resolutionin mitotic prophase[J]. Curr Biol, 2006,16(24) : 2406-2417.
  • 7Kuroda M,Oikawa K,Yoshida K,et al. Effects of 3-methylcholan- threne on the transcriptional activity and mRNA accumulation of the oncogene hWAPL[J]. Cancer Letters, 2005,221 (1) : 21-28.
  • 8卢晓芬,张树泉,孔爱荣.hWAPL基因在宫颈癌中作用的研究进展[J].肿瘤学杂志,2007,13(6):509-511. 被引量:2
  • 9Zhuqing Ouyang,Ge Zheng,Jianhua Song,Dominika M. Borek,Zbyszek Otwinowski,Chad A. Brautigam,Diana R. Tomchick,Susannah Rankin,Hongtao Yu.Structure of the human cohesin inhibitor Wapl[J].Proceedings of the National Academy of Sciences.2013(28)
  • 10Benjamin D. Rowland,Maurici B. Roig,Tatsuya Nishino,Alexander Kurze,Pelin Uluocak,Ajay Mishra,Frédéric Beckou?t,Philippa Underwood,Jean Metson,Richard Imre,Karl Mechtler,Vittorio L. Katis,Kim Nasmyth.Building Sister Chromatid Cohesion: Smc3 Acetylation Counteracts an Antiestablishment Activity[J].Molecular Cell.2009(6)

共引文献9

同被引文献110

  • 1Zheng X, Liang P, Zheng Y, et al. Clinical significance of hTERC gene detection in exfoliated cervical epithelial cells for cervical lesions[J]. IntJ Gynecol Cancer, 2013, 23(5): 785-790.
  • 2Liu X, Liu Z, Tian H. The infection and prevention of Human Papillomavirus[M]. Beijing: People's Medical Publishing House, 2009.
  • 3Boyle P, Vecchia C, Walker A, et al. FIGO annual report on the results of treatmenting gynecological cancer[J]. J Epidemiol Biostat, 2001, 12: 743-744.
  • 4Foley G, Alston R, Geraci M, et al. Increasing rates of cervical cancer in young women in England: an anlysis of national data 1982-2006[J]. BrJ Cancer, 2011, 105(1): 177-178.
  • 5D'Hauwers KWM, Gadet PFE, Donders ART, et al. Impact of medical education on knowledge and attitudes regarding the human papilloma virus and vaccination: Comparison before and 6 years after the introduction of the vaccines[J]. Vaccine, 2013, 31(49): 5843-5847.
  • 6Wu R, Dai M, Qjao Y, et al. Human papiUomavirus infection in women in Shenzhen, People's Republic of China, apopulation typical of recent Chinese urbanization[J]. Int J Cancer, 2007, 121(6): 1306.
  • 7Lowy DR, Schiller JT. Prophylactic human papillomavirus vaccines[J]. J Clin Invest, 2006, 116(5): 1167-1173.
  • 8Chan PG, Sung HY, Sawaya GF. Changes in cervical cancer incidence after three decades of screening US women less than 30 years old[J]. Obstet Gynecol, 2003, 102(4): 765-773.
  • 9JEMAL A, BRAY F, CENTER MM, et al. Global cancer statistics [ J]. CA Cancer J Clin,2011,61 (2) :69.
  • 10LI N, FRANCESCHI S, HOWELL-JONES R, et al. Human papillomavirus type distribution in 30,848 invasive cervi- cal cancers worldwide: variation by geographical region, histological type and year of publication[ Jl. Int J Cancer, 2011,128(4) :927.

引证文献12

二级引证文献72

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部